A Blackrock representative said it’s the final step as the company prepares to launch its first commercial product early next year.
Salt Lake City-based Blackrock plans to submit its first commercial BCI device, called MoveAgain, to the FDA this year.
Blackrock wants its BCI platform to be the first one that’s commercially available to people with paralysis. Its implant has been used in patients since 2004 through research studies, with zero FDA-reported serious adverse events since then.
Get the full story at our sister site, Medical Design & Outsourcing.